FDA
approval
· 2011-01-24
FDA Approved: OXALIPLATIN — Original Application (Sandoz Inc)
Summary
FDA approved Sandoz's generic oxaliplatin through an Original Application (ANDA). The approval supports the use of oxaliplatin for colorectal cancer treatment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OXALIPLATIN (OXALIPLATIN)